Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Astec LifeSciences has informed that a Meeting of the Board of Directors of the Company (‘Board’) is scheduled to be held on Monday, 27th April, 2026 to, consider and approve the Standalone and Consolidated Audited Financial Results & Statements of the Company for the Quarter and Financial Year ended March 31, 2026, after these results are reviewed by the Audit Committee. The copy of the intimation is also available on the website of the company at https://www.godrejastec.com.
The above information is a part of company’s filings submitted to BSE.
